Danaher Corporation  

(Public, NYSE:DHR)   Watch this stock  
Find more results for John Coulter´┐Ż
91.77
+0.44 (0.48%)
Real-time:   3:57PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 91.08 - 92.42
52 week 70.12 - 92.42
Open 91.26
Vol / Avg. 2.10M/4.84M
Mkt cap 62.25B
P/E 25.27
Div/yield 0.14/0.59
EPS 3.63
Shares 683.49M
Beta 1.25
Inst. own 82%
Oct 14, 2015
Q3 2015 Danaher Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 23, 2015
Q2 2015 Danaher Corp Earnings Call
Jul 23, 2015
Q2 2015 Danaher Corp Earnings Release
Jun 11, 2015
Danaher Corp Investor and Analyst Event
Jun 3, 2015
Danaher Corp at Deutsche Bank Global Industrials and Basic Materials Conference
May 28, 2015
Danaher Corp at Sanford C Bernstein Strategic Decisions Conference
May 18, 2015
Danaher Corp at Electrical Products Group Conference
May 7, 2015
Danaher Corp Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '15) 2014
Net profit margin 13.57% 13.05%
Operating margin 18.16% 17.23%
EBITD margin - 21.94%
Return on average assets 7.64% 7.25%
Return on average equity 11.77% 11.36%
Employees 71,000 -
CDP Score - 12

Address

2200 Pennsylvania Ave NW Ste 800w
WASHINGTON, DC 20037-1731
United States - Map
+1-202-8280850 (Phone)
+1-202-8280860 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. The Test & Measurement segment offers test, measurement and monitoring products. The Environmental segment products and services help protect the global water supply, facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments, reagents, consumables, software and services. The Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply, improve packaging design and quality, verify pharmaceutical dosages and authenticity and power innovative machines.

Officers and directors

Steven M. Rales Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel L. Comas Chief Financial Officer, Executive Vice President
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mitchell P. Rales Chairman of the Executive Committee, Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark A. Beck Executive Vice President
Age: 49
Bio & Compensation  - Reuters
William K. Daniel II Executive Vice President
Age: 50
Bio & Compensation  - Reuters
James A. Lico Executive Vice President
Age: 49
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James H. Ditkoff Senior Vice President - Finance and Tax
Age: 68
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Lutz Senior Vice President, Chief Accounting Officer
Age: 57
Bio & Compensation  - Reuters
Jonathan P. Graham Senior Vice President, General Counsel
Age: 54
Bio & Compensation  - Reuters
Angela S. Lalor Senior Vice President - Human Resources
Age: 49
Bio & Compensation  - Reuters